| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $173.6M | +5.7% |
| Cost of Revenue | $39.0M | -7.5% |
| R&D Expense | $42.8M | -8.0% |
| SG&A Expense | $51.7M | -20.7% |
| Operating Income | $21.7M | +303.7% |
| Pre-tax Income | $13.8M | +147.0% |
| Income Tax | $7.6M | +60.5% |
| Net Income | $6.2M | +111.3% |
| EPS (Basic) | $0.46 | +106.9% |
| EPS (Diluted) | $0.43 | +106.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.4M | +35.8% |
| Accounts Receivable | $18.1M | -22.8% |
| Current Assets | $81.4M | -0.8% |
| Total Assets | $293.8M | -5.3% |
| Current Liabilities | $40.3M | -15.5% |
| Long-term Debt | $186.7M | +37.1% |
| Total Liabilities | $251.6M | +18.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.3M | +50.2% |
| Capital Expenditures | $1.9M | +45.6% |
| Investing Cash Flow | -$13.1M | -445.5% |
| Financing Cash Flow | -$5.9M | +70.7% |
| Free Cash Flow | $26.4M | +50.5% |
| Stockholders' Equity |
| $29.8M |
| +11.8% |